期刊
CURRENT PHARMACEUTICAL DESIGN
卷 6, 期 7, 页码 717-732出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1381612003400498
关键词
-
The role of 1,25-dihydloxyvitamin D-3 (1,25-(OH)(2)D-3) as a regulator of cell growth and differentiation is well recognized. Currently, 1,25-(OH)2D3 and vitamin D analogs are being evaluated for their therapeutic potential in the treatment 1 of hypelproliferative disorders like cancer. In the present review, we will discuss several processes that might be involved in 1,25-(OH)(2)D-3- and vitamin D analog-mediated suppression of cancer cell growth. The effects on turner cell proliferation, differentiation, apoptosis, angiogenesis, metastases, and parathyroid hormone-related peptide secretion will be highlighted. In addition, combination therapy with other tumor effective drugs will be addressed. Furtermore, we will focus on the potential drawbacks and the possible side effects of vitamin D compounds in the treatment of cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据